A Randomized, Placebo-Controlled, Parallel-Group Comparative Clinical Study to Evaluate the Efficacy and Safety of a Hair Serum Alone and in Combination with Gummies, Compared to Placebo, in Reducing Hair Fall and Promoting Hair Growth in Male and Female Participants.

This study will enroll 105 male and female participants (7:3 ratio) who meet the eligibility criteria and provide informed consent. The study is designed to compare the test products with placebo, as well as evaluate differences within the treatment groups, At screening (Visit 1, Day –16), participants will undergo health screening, medical history, and dermatological evaluation, followed by a Trichoscan at Visit 2 (Day –14) before a two-week washout period, during which they will stop all hair growth products and use a neutral shampoo.

Baseline assessments at Week 0 (Visit 3, Day 0) will include imaging, dermatological and instrumental tests, hair comb test, Trichoscan, and self-assessment. At Visit 4 (Day 2), participants will undergo Trichoscan, be randomized into three groups, receive the study product, and start daily diary recording.

Follow-up visits at Weeks 4, 8, and 12 will repeat baseline assessments. The final visit will include product and diary collection and study exit procedures. Site application reactions, concomitant medications, and any adverse events will be monitored throughout.